Hair Banking Offers Potential, But Remains Unproven

The experimental treatment is available at some clinics, but the cloning technology is not yet FDA-approved.

Updated on Oct. 16, 2026 in Beauty

Gouache-painted illustration of a single hair follicle bulb in a clear vial, representing the experimental practice of hair banking.
Clinics are now offering hair banking services to cryopreserve follicles, although the cloning technology required for reinsertion remains experimental and unapproved. AI Illustration. Upload story photo >

Live Poll

Would you pay for an experimental medical treatment with no guaranteed outcome for your health?

Hair banking involves harvesting and cryopreserving hair follicles for potential future use in transplants. This emerging practice is currently available at 10 U.S. clinics, though the associated cloning technology remains in development.

Why it matters

Proponents suggest banking follicles preserves hair with the most longevity for later transplantation, potentially streamlining the process. However, as the underlying cloning technology is not yet FDA-approved and lacks consistent results, prospective patients face significant uncertainties.

Hair banking requires the extraction of 100 follicles for cryopreservation, a process that occurs before subsequent cloning attempts. While clinical testing began in March 2026, the technique is currently under development and efficacy remains unproven.

The players

HairClone

A biotechnology company focused on follicle cryopreservation and the development of hair cloning technology.

The details

Professionals perform the banking process by extracting 100 hair follicles from a patient using a method called Follicular Unit Extraction. These follicles are then cryopreserved and sent abroad to be multiplied using cloning technology. Once the cells are expanded, they are intended for later reinsertion, though they do not currently take consistently in scalp transplants.

Timeline

  1. 2019: HairClone began follicle cryopreservation and banking.

  2. March 2026: HairClone started clinical testing.

Health Landscape

Hair banking represents a shift toward using regenerative medicine to address hair thinning compared to standard transplant methods. It attempts to extend the capabilities of established Follicular Unit Extraction by integrating long-term cell storage and future cloning.

Patients should be aware that hair banking requires ongoing yearly storage costs in addition to the initial extraction and eventual transplant fees. Any interest in this experimental process is worth discussing with your doctor to understand the lack of FDA approval and current limitations.

The takeaway

While banking follicles may seem like a proactive step for future hair loss, the science is still in its early stages and has not achieved consistent, reliable outcomes. Always prioritize discussions with a medical professional regarding the long-term costs and lack of regulatory approval for these techniques.

Further reading

For a broader look at treatments, visit our Beauty section.

Source note: This article includes information reported by The Daily Beast.

Live Poll

Would you pay for an experimental medical treatment with no guaranteed outcome for your health?